- Dexcom Announces Upcoming Conference Presentations
- DexCom Promotes Jake Leach to Chief Operating Officer
- Dexcom Announces Upcoming Conference Presentation
- Dexcom ONE real-time Continuous Glucose Monitoring (rt-CGM) System available on prescription in the UK, improving access to rt-CGM for people with diabetes
- Dexcom Reports Second Quarter 2022 Financial Results
- Dexcom G6 Continuous Glucose Monitoring System Mobile App Now Available in Spanish
- Dexcom Canada Achieves Great Place to Work® Certification
- Dexcom Schedules Second Quarter 2022 Earnings Release and Conference Call for July 28, 2022 at 4:30 p.m. Eastern Time.
Dexcom Inc (DXCM*:MEX) closed at 1,845.00, 25.51% above the 52 week low of 1,470.00 set on May 24, 2022.
1,470.00May 24 20223,366.38Nov 16 2021
Markit short selling activity
|Market cap||31.67bn USD|
|EPS (TTM)||0.4741 |
Data delayed at least 20 minutes, as of Sep 08 2022 14:04 BST.